These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15073130)

  • 61. Targeting HER2: recent developments and future directions for breast cancer patients.
    Wang SC; Zhang L; Hortobagyi GN; Hung MC
    Semin Oncol; 2001 Dec; 28(6 Suppl 18):21-9. PubMed ID: 11774202
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Phase II study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer.
    Baselga J; Tripathy D; Mendelsohn J; Baughman S; Benz CC; Dantis L; Sklarin NT; Seidman AD; Hudis CA; Moore J; Rosen PP; Twaddell T; Henderson IC; Norton L
    Semin Oncol; 1999 Aug; 26(4 Suppl 12):78-83. PubMed ID: 10482197
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chemoprevention activity of dipyridamole in the MMTV-PyMT transgenic mouse model of breast cancer.
    Wang C; Schwab LP; Fan M; Seagroves TN; Buolamwini JK
    Cancer Prev Res (Phila); 2013 May; 6(5):437-47. PubMed ID: 23447563
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antiangiogenic and antitumor activities of berberine derivative NAX014 compound in a transgenic murine model of HER2/neu-positive mammary carcinoma.
    Pierpaoli E; Damiani E; Orlando F; Lucarini G; Bartozzi B; Lombardi P; Salvatore C; Geroni C; Donati A; Provinciali M
    Carcinogenesis; 2015 Oct; 36(10):1169-79. PubMed ID: 26168818
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.
    Marchini C; Gabrielli F; Iezzi M; Zenobi S; Montani M; Pietrella L; Kalogris C; Rossini A; Ciravolo V; Castagnoli L; Tagliabue E; Pupa SM; Musiani P; Monaci P; Menard S; Amici A
    PLoS One; 2011 Apr; 6(4):e18727. PubMed ID: 21559085
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis.
    Chen H; Lee JS; Liang X; Zhang H; Zhu T; Zhang Z; Taylor ME; Zahnow C; Feigenbaum L; Rein A; Sukumar S
    Cancer Res; 2008 May; 68(10):3637-44. PubMed ID: 18463397
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.
    Maglione JE; McGoldrick ET; Young LJ; Namba R; Gregg JP; Liu L; Moghanaki D; Ellies LG; Borowsky AD; Cardiff RD; MacLeod CL
    Mol Cancer Ther; 2004 Aug; 3(8):941-53. PubMed ID: 15299077
    [TBL] [Abstract][Full Text] [Related]  

  • 68. 213Bi (alpha-emitter)-antibody targeting of breast cancer metastases in the neu-N transgenic mouse model.
    Song H; Shahverdi K; Huso DL; Esaias C; Fox J; Liedy A; Zhang Z; Reilly RT; Apostolidis C; Morgenstern A; Sgouros G
    Cancer Res; 2008 May; 68(10):3873-80. PubMed ID: 18483272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers.
    Menon R; Omenn GS
    Cancer Res; 2010 May; 70(9):3440-9. PubMed ID: 20388783
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer.
    Ferguson RD; Gallagher EJ; Cohen D; Tobin-Hess A; Alikhani N; Novosyadlyy R; Haddad N; Yakar S; LeRoith D
    Endocr Relat Cancer; 2013 Jun; 20(3):391-401. PubMed ID: 23572162
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
    Dillon RL; Marcotte R; Hennessy BT; Woodgett JR; Mills GB; Muller WJ
    Cancer Res; 2009 Jun; 69(12):5057-64. PubMed ID: 19491266
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics.
    Reyzer ML; Caldwell RL; Dugger TC; Forbes JT; Ritter CA; Guix M; Arteaga CL; Caprioli RM
    Cancer Res; 2004 Dec; 64(24):9093-100. PubMed ID: 15604278
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Veterinary Management of Harderian Gland Tumors in Cancer Rainbow (crainbow) HER2-Positive Mice.
    Garner A; Ginzel JD; Snyder JC; Everitt JI; Landon CD
    Comp Med; 2022 Dec; 72(6):403-409. PubMed ID: 36744508
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression.
    Pitteri SJ; Kelly-Spratt KS; Gurley KE; Kennedy J; Buson TB; Chin A; Wang H; Zhang Q; Wong CH; Chodosh LA; Nelson PS; Hanash SM; Kemp CJ
    Cancer Res; 2011 Aug; 71(15):5090-100. PubMed ID: 21653680
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolomic changes accompanying transformation and acquisition of metastatic potential in a syngeneic mouse mammary tumor model.
    Lu X; Bennet B; Mu E; Rabinowitz J; Kang Y
    J Biol Chem; 2010 Mar; 285(13):9317-9321. PubMed ID: 20139083
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model.
    Ghosh SK; Uchida M; Yoo B; Ross AW; Gendler SJ; Gong J; Moore A; Medarova Z
    Int J Cancer; 2013 Apr; 132(8):1860-7. PubMed ID: 23015160
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Context-dependent effects of whole-genome duplication during mammary tumor recurrence.
    Newcomb R; Dean E; McKinney BJ; Alvarez JV
    Sci Rep; 2021 Jul; 11(1):14932. PubMed ID: 34294755
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Loss of the extracellular matrix glycoprotein EMILIN1 accelerates Δ16HER2-driven breast cancer initiation in mice.
    Favero A; Segatto I; Capuano A; Mattevi MC; Rampioni Vinciguerra GL; Musco L; D'Andrea S; Dall'Acqua A; Gava C; Perin T; Massarut S; Marchini C; Baldassarre G; Spessotto P; Belletti B
    NPJ Breast Cancer; 2024 Jan; 10(1):5. PubMed ID: 38184660
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of 2-methoxyestradiol treatment on early- and late-stage breast cancer progression in a mouse model.
    Peta KT; Durandt C; van Heerden MB; Joubert AM; Pepper MS; Ambele MA
    Cell Biochem Funct; 2023 Oct; 41(7):898-911. PubMed ID: 37649158
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dietary depletion of vitamin E and vitamin A inhibits mammary tumor growth and metastasis in transgenic mice.
    Albright CD; Salganik RI; Van Dyke T
    J Nutr; 2004 May; 134(5):1139-44. PubMed ID: 15113960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.